Trauma e medicina de urgência
Manejo e reversão da anticoagulação
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (abre nova janela)
Fonte: Lancet 2015;385(9982):2077-87.
Indexado: PubMed 25728933
DOI: 10.1016/S0140-6736(14)61685-8
https://www.ncbi.nlm.nih.gov/pubmed/25728933 (abre nova janela)
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (abre nova janela)
Fonte: Am J Hematol 2012;87 Suppl 1:S141-5.
Indexado: PubMed 22473649
DOI: 10.1002/ajh.23202
https://www.ncbi.nlm.nih.gov/pubmed/22473649 (abre nova janela)
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (abre nova janela)
Fonte: J Thromb Haemost 2011;9(9):1705-12.
Indexado: PubMed 21729240
DOI: 10.1111/j.1538-7836.2011.04432.x
https://www.ncbi.nlm.nih.gov/pubmed/21729240 (abre nova janela)
Emergency reversal of warfarin anticoagulation. (abre nova janela)
Fonte: CMAJ 2010;182(18):2004.
Indexado: PubMed 21078740
DOI: 10.1503/cmaj.100983
https://www.ncbi.nlm.nih.gov/pubmed/21078740 (abre nova janela)
Management of anticoagulation agents in trauma patients. (abre nova janela)
Fonte: Clin Lab Med 2014;34(3):563-74.
Indexado: PubMed 25168942
DOI: 10.1016/j.cll.2014.06.013
https://www.ncbi.nlm.nih.gov/pubmed/25168942 (abre nova janela)
Idarucizumab for dabigatran reversal - full cohort analysis. (abre nova janela)
Fonte: N Engl J Med 2017;377(5):431-41.
Indexado: PubMed 28693366
DOI: 10.1056/NEJMoa1707278
https://www.ncbi.nlm.nih.gov/pubmed/28693366 (abre nova janela)
Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (abre nova janela)
Fonte: Anesth Analg 2011;113(4):703-10.
Indexado: PubMed 21890888
DOI: 10.1213/ANE.0b013e318228c690
https://www.ncbi.nlm.nih.gov/pubmed/21890888 (abre nova janela)
Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (abre nova janela)
Fonte: World Neurosurg 2014;81(1):110-5.
Indexado: PubMed 23220122
DOI: 10.1016/j.wneu.2012.12.002
https://www.ncbi.nlm.nih.gov/pubmed/23220122 (abre nova janela)